Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

HCW Biologics Q2 EPS $(6.79) Misses $1.80 Estimate, Sales $6.550K Miss $7.000M Estimate

Author: Benzinga Newsdesk | August 18, 2025 01:46pm
HCW Biologics (NASDAQ:HCWB) reported quarterly losses of $(6.79) per share which missed the analyst consensus estimate of $1.80 by 477.22 percent. This is a 57.98 percent increase over losses of $(16.16) per share from the same period last year. The company reported quarterly sales of $6.550 thousand which missed the analyst consensus estimate of $7.000 million by 99.91 percent. This is a 98.94 percent decrease over sales of $618.854 thousand the same period last year.

Posted In: HCWB


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist